Hims & Hers Health, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Hims & Hers Health, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 61.9 times by its yearly operating cash. Higher than 96% of Healthcare companies in United States.
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $4 per $100 of sales comes from others' credit, against $2 from others' credit three years earlier. Less money tied up than 93% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
$271Over the last 3 years, every $100 of reported profit came with $271 of operating cash.
Higher than 85% of Healthcare companies in United States.
Self-Funding Ratio
1.9×Over the last 3 years its own operating cash covered its investment spending (capex) 1.9 times.
Higher than 74% of Healthcare companies in United States.
Cash Locked Ratio
−$4Money owed to suppliers is larger than money owed by customers plus stock: $4 per $100 of sales comes from others' credit, against $2 from others' credit three years earlier.
Less money tied up than 93% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
$11Sales grew 346% in 3 years; of every extra $100 of sales, $11 became extra profit.
Lower than 58% of Healthcare companies in United States.
Asset Productivity Ratio
+346% / +488%In 3 years sales changed by +346% while total assets changed by +488%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
61.9×Debt due within a year is covered 61.9 times by its yearly operating cash.
Higher than 96% of Healthcare companies in United States.
Cash Cushion Ratio
−8%Debt, after subtracting cash, equals 8% of its market value (net debt).
Lower than 77% of Healthcare companies in United States.
Tangible Assets Ratio
78%Of every $100 the company owns, $78 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 54% of Healthcare companies in United States.
Tangible Net Worth Ratio
12%Of every $100 of net worth, $12 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 68% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Hims & Hers Health, Inc. made a loss over the last year. Hims & Hers Health, Inc. owes $0.91 for every $1 it owns. Net profit rose 2% in the year to Dec 2025.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossHims & Hers Health, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
20.97The share price is 20.97 times Hims & Hers Health, Inc.'s book value per share, higher than 94% of Healthcare companies in United States.
Market cap
$6.8 BThe total market value of all of Hims & Hers Health, Inc.'s shares at today's price (share price × number of shares), larger than 87% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$324 MWhat Hims & Hers Health, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.39Net worth divided by the number of shares. The share price of $29.13 is 21.0 times this, which is the P/B above.
Return on equity (ROE)
-32.0%Hims & Hers Health, Inc. lost 32.0% of its shareholders' money over the last year, higher than 60% of Healthcare companies in United States.
Owes vs Owns
0.91×Hims & Hers Health, Inc. owes $0.91 for every $1 it owns (high), higher than 83% of Healthcare companies in United States.
Dividend yield
NoneHims & Hers Health, Inc. does not currently pay a dividend.
Revenue growth
+59%Revenue rose 59% in the year to Dec 2025, and grew 65% a year on average over 3 years.
Profit growth
+2%Net profit rose 2% in the year to Dec 2025.
Profit margin
5.5%Hims & Hers Health, Inc. keeps $5 of every $100 of revenue as net profit.
Cash quality
2.3×Cash from Hims & Hers Health, Inc.'s business was 2.3× its reported profit in the year to Dec 2025 — its profit turned into cash.
Cash vs debt
Net debtHims & Hers Health, Inc. had $543 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Hims & Hers Health, Inc.: $6.8 B ÷ $324 M (30 Jun 2026) = 21.0.
What is Hims & Hers Health, Inc.'s return on equity?
Hims & Hers Health, Inc. lost 32.0% of its shareholders' money over the last year, higher than 60% of Healthcare companies in United States.
How much does Hims & Hers Health, Inc. owe compared with what it owns?
Hims & Hers Health, Inc. owes $0.91 for every $1 it owns (high), higher than 83% of Healthcare companies in United States.
Does Hims & Hers Health, Inc. pay a dividend?
No. Hims & Hers Health, Inc. does not currently pay a dividend.
Is Hims & Hers Health, Inc.'s revenue growing?
Revenue rose 59% in the year to Dec 2025, and grew 65% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.